Home  |  Contact Us  |  Site Map
| MENU |

Clinical / Clinicopathologic Observations

Campoli M, Brodland DG, Zitelli J. A prospective evaluation of the clinical, histologic, and therapeutic variables associated with incidental perineural invasion in cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2014 Jan 13.

Verneuil L, Varna M, Ratajczak P, Leboeuf C, Plassa LF, Elbouchtaoui M, et al. Human skin carcinoma arising from kidney transplant-derived tumor cells. J Clin Invest. 2013 Sep 3;123(9):3797–801.

Mougel F, Kanitakis J, Faure M, Euvrard S. Basosquamous cell carcinoma in organ transplant patients: a clinicopathologic study. J Am Acad Dermatol. 2012 May;66(5):e151-7. doi: 10.1016/j.jaad.2010.11.045. Epub 2011 Jun 22. PubMed PMID: 21696852. 

Bagazgoitia L, Cuevas Santos J, Juarranz A, Jaén P. Photodynamic therapy reduces the histological features of actinic damage and the expression of early oncogenic markers. Br J Dermatol. 2011 Jul;165(1):144-51. doi: 10.1111/j.1365-2133.2011.10270.x. Epub 2011 May 26. PubMed PMID: 21615716. 

Sung W, Sam H, Deleyiannis FW. Subungual squamous cell carcinoma after organ transplantation. J Am Podiatr Med Assoc. 2010 Jul-Aug;100(4):304-8. PubMed PMID:  20660884. 

Gutiérrez-Dalmau A, Revuelta I, Ferrer B, Mascaró JM Jr, Oppenheimer F, Albanell J, Campistol JM. Distinct immunohistochemical phenotype of nonmelanoma skin cancers between renal transplant and immunocompetent populations. Transplantation. 2010 Nov 15;90(9):986-92. doi: 10.1097/TP.0b013e3181f6a0a1. PubMed PMID: 20844469.

Carroll RP, Segundo DS, Hollowood K, Marafioti T, Clark TG, Harden PN, Wood KJ. Immune phenotype predicts risk for posttransplantation squamous cell carcinoma. J Am Soc Nephrol. 2010 Apr;21(4):713-22. doi: 10.1681/ASN.2009060669. Epub 2010 Jan 28. PubMed PMID: 20110382; PubMed Central PMCID: PMC2844307. 

Krynitz B, Lundh Rozell B, Lindelöf B. Differences in the peritumoural inflammatory skin infiltrate between squamous cell carcinomas in organ transplant recipients and immunocompetent patients. Acta Derm Venereol. 2010 Jul;90(4):379-85. doi: 10.2340/00015555-0876. PubMed PMID: 20574603.

Lally A, Casabonne D, Waterboer T, Imko-Walczuk B, Michael KM, Pawlita M, Newton R, Wojnarowska F. Association of seborrhoeic warts with skin cancer in renal transplant recipients. J Eur Acad Dermatol Venereol. 2010 Mar;24(3):302-7. doi: 10.1111/j.1468-3083.2009.03412.x. Epub 2009 Sep 1. PubMed PMID: 19732252.

Cooper JZ, Brown MD. Special concern about squamous cell carcinoma of the scalp in organ  transplant recipients. Arch Dermatol. 2006 Jun;142(6):755-8. PubMed PMID: 16785379.

Kovach BT, Sams HH, Stasko T. Multiple atypical fibroxanthomas in a cardiac transplant recipient. Dermatol Surg. 2005 Apr;31(4):467-70. PubMed PMID: 15871326.

Martinez JC, Otley CC, Stasko T, Euvrard S, Brown C, Schanbacher CF, WeaverAL; Transplant-Skin Cancer Collaborative. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a Multicenter collaborative study. Arch Dermatol. 2003 Mar;139(3):301-6. PubMed PMID: 12622621.

Mehrany K, Byrd DR, Roenigk RK, Weenig RH, Phillips PK, Nguyen TH, Otley CC. Lymphocytic infiltrates and subclinical epithelial tumor extension in patients with chronic leukemia and solid-organ transplantation. Dermatol Surg. 2003 Feb;29(2):129-34. PubMed PMID: 12562340.

Boyd AS, Stasko T, Cameron GS, Russell M, King LE Jr. Histologic features of actinic keratoses in solid organ transplant recipients and healthy controls. J Am Acad Dermatol. 2001 Aug;45(2):217-21. PubMed PMID: 11464182.



Updated on Friday, January 11th, 2013

ITSCC

Your tax-deductible donation supports the education and research of physicians and scientists committed to improving the quality of life of organ transplant recipients. If you are unable to donate online or require other information to make a gift through a trust or other source, email info@itscc.org for additional assistance. ITSCC's federal tax ID is 43-1964114.

Support ITSCC video

ITSCC is a nonprofit 501(c)(3) organization, and has received support through unrestricted educational grants from pharmaceutical companies and donations of time and funds from physicians, researchers, transplant patients and their families.